Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2Other hematologic neoplasm 1Lymphoid 1

Conditions

Thrombocytopenia 6Leukemia, Myeloid, Acute 6Leukemia 6Myelodysplastic Syndromes 4Leukemia, Myelomonocytic, Chronic 3Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Jacobs syndrome 2Recurrence 1Purpura, Thrombocytopenic, Idiopathic 1Myeloproliferative Disorders 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma, B-Cell 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Hematologic Neoplasms 1Congenital Abnormalities 1Chemotherapy-induced Thrombocytopenia 1Bone Marrow Failure Disorders 1Anemia, Refractory, with Excess of Blasts 1Anemia 1

Interventions

eltrombopag 2avatrombopag 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Jacobs syndrome × eltrombopag × Clear all
NCT01168921 2023-03-23

Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL)

M.D. Anderson Cancer Center

Phase 2 Completed
23 enrolled 9 charts
Classical hematologyLymphoidOther hematologic neoplasm

Jacobs syndrome, Leukemia, Thrombocytopenia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00102726 2017-03-23

SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy

GlaxoSmithKline

Phase 2 Completed
183 enrolled
Classical hematology

Jacobs syndrome, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡